Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
474 studies found for:    Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Not yet recruiting Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain
Conditions: Chronic Pain;   Chronic Low Back Pain
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Transcranial Ultrasound (TUS)
22 Recruiting L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: L-methylfolate;   Drug: OROS-Methylphenidate
23 Recruiting Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
Conditions: Attention Deficit Disorder;   Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine;   Drug: Placebo
24 Recruiting Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study
Conditions: Spinal Cord Injury;   Chronic Pain
Interventions: Other: Education Program Type 1;   Other: Education Program Type 2
25 Not yet recruiting Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer
Condition: Metastatic Brain Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Radiation: Stereotactic Radiosurgery (SRS);   Radiation: Whole Brain Radiation Therapy (WBRT);   Behavioral: Neurocognitive Exam
26 Recruiting Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Condition: Chronic Aphasia
Interventions: Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
27 Recruiting A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
Condition: Ischemic Stroke
Interventions: Drug: BMS-986141;   Drug: Dilitazem
28 Recruiting Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Conditions: Transient Ischemic Attack;   Stroke;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Warfarin
29 Recruiting A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Condition: Cancer of Brain and Nervous System
Intervention: Device: bevacizumab, NovoTTF100A, temozolomide
30 Recruiting AMPLATZER™ Amulet™ LAA Occluder Trial
Condition: Stroke
Interventions: Device: Amulet Left Atrial Appendage Occluder;   Device: WATCHMAN Left Atrial Appendage Closure
31 Recruiting Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection
Conditions: Brain Tumor;   High Grade Glioma
Intervention: Drug: topotecan
32 Recruiting Nivolumab With DC Vaccines for Recurrent Brain Tumors
Conditions: Malignant Glioma;   Astrocytoma;   Glioblastoma
Interventions: Drug: nivolumab;   Biological: DC
33 Recruiting Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Condition: Partial Epilepsy
Intervention: Drug: YKP3089
34 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
35 Recruiting Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Conditions: Lymphoma;   Neuroblastoma;   Brain Tumor;   Solid Tumor
Intervention: Drug: CUDC-907
36 Recruiting Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SPD489
37 Recruiting Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Autoimmune Diseases;   Autoimmune Diseases of the Nervous System;   Nervous System Diseases
Intervention: Procedure: Harvesting and Implantation of SVF
38 Recruiting Phase I Study of Safety and Immunogenicity of ADU-623
Conditions: Astrocytic Tumors;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Brain Tumor
Interventions: Biological: Cohort 1;   Biological: Cohort 2;   Biological: Cohort 3;   Drug: Antibiotics
39 Recruiting A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: dasotraline 4mg;   Other: Placebo
40 Recruiting Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Conditions: Breast Cancer;   Brain Tumor - Metastatic
Interventions: Drug: Cabozantinib;   Drug: Trastuzumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.